Differential proteolytic activity and induction of apoptosis in fibrous versus atheromatous plaques in carotid atherosclerotic disease.
OBJECTIVE
Atherosclerotic plaque instability may be a contributing factor to plaque complications, such as rupture, thrombosis, and embolization. Of the two types of plaques, atheromatous and fibrous, the atheromatous type has been reported to be vulnerable and unstable. This instability may be related to changes in the cell cycle and extracellular matrix degradation. Apoptosis may weaken the plaque structurally. In addition, alteration of the cellular component may lead to imbalances in associated proteolytic activity. Our study was designed to compare the two types of plaques in terms of apoptosis, apoptosis-inducing factors, namely Fas/CD95/APO-1 and CPP-32/YAMA/caspase-3, and proteolytic activity.


METHODS
Carotid artery plaques were obtained from patients undergoing endarterectomy and were classified as either atheromatous or fibrous on the basis of established criteria. Histologic study included hematoxylin and eosin staining, Verhoeff's van Gieson elastin staining, and trichrome staining. Detection of apoptosis was performed with the TUNEL assay. Immunohistochemical studies were performed to localize the expression of CPP-32/YAMA and Fas/CD95. Gelatin gel zymography was used to compare proteolytic activity levels in the two types of plaque.


RESULTS
Apoptosis was significantly higher (P <.001) in atheromatous plaques (4.90% +/- 1.27% [SEM]) as compared with fibrous plaques (0.86% +/- 0.46% [SEM]). Zymography demonstrated elevated levels of proteinases in atheromatous plaques. Immunohistochemistry revealed significant increases in the expression of Fas/CD95 (P <.04) and CPP-32/YAMA (P <.001) in atheromatous plaques as compared with that in fibrous plaques.


CONCLUSIONS
This is the first study comparing molecular factors that render atheromatous plaques more susceptible to rupture than fibrous plaques. The higher number of apoptotic cells seen in atheromatous plaques as compared with fibrous plaques could contribute to their greater instability. Immunoreactivity to cytoplasmic death domain, Fas/CD95 and CPP-32/YAMA, a prominent mediator of apoptosis, was consistent with the numbers of apoptotic cells detected. The increased levels of proteolytic activity in atheromatous plaques may make these plaques more prone to rupture. These data identifying some of the molecular events and biochemical pathways associated with plaque vulnerability may help in the development of new strategies to prevent plaque rupture.
Division of Vascular Surgery and the Department of Pathology, Maimonides Medical Center, Brooklyn, NY 11219, USA.
T
T
Jacob
E
E
Ascher
A
A
Hingorani
Y
Y
Khandros
B
B
Tsemekhin
L
L
Zeien
Y
Y
Gunduz
D000368:Aged; D000369:Aged, 80 and over; D017209:Apoptosis / Q000502:physiology*; D051033:Apoptosis Inducing Factor; D001161:Arteriosclerosis / Q000473:pathology* / Q000601:surgery; D016893:Carotid Stenosis / Q000473:pathology* / Q000601:surgery; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism; D016894:Endarterectomy, Carotid; D005260:Female; D005420:Flavoproteins / Q000378:metabolism*; D006801:Humans; D008297:Male; D008565:Membrane Proteins / Q000378:metabolism*; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000378:metabolism*; D019014:fas Receptor / Q000378:metabolism
C494829:AIFM1 protein, human; D051033:Apoptosis Inducing Factor; D005420:Flavoproteins; D008565:Membrane Proteins; D019014:fas Receptor; D010447:Peptide Hydrolases; C505407:CASP3 protein, human; D053148:Caspase 3; D020169:Caspases